Max MyHealth Digital Platform & CSR Initiatives
MAX
Healthcare
Network P&L Statement: Q3 FY24
Gross revenue
Net revenue
Direct costs¹
Figs in INR Cr
Q3 FY23
Q2 FY24
Q3 FY24
Amount
% NR
Amount
% NR
Amount
% NR
1,559
1,827
1,779
1,478
100.0%
1,732
100.0%
1,689
100.0%
573
38.8%
667
38.5%
650
38.5%
905
61.2%
1,065
61.5%
1,038
61.5%
486
32.9%
567
32.8%
567
33.6%
Contribution
Indirect overheads²
Operating EBITDA (post Ind AS-116)
419
28.3%
497
28.7%
471
27.9%
ESOP (Equity-settled scheme)
12
0.8%
12
0.7%
12
0.7%
Movement in fair value of contingent consideration payable
and amortisation of contract assets³
6
0.4%
7
0.4%
(8)
(0.5%)
Reported EBITDA
401
27.1%
478
27.6%
467
27.7%
Finance cost (net) 4
7
0.5%
(17)
(1.0%)
(14)
(0.8%)
Depreciation and amortisation
Profit before tax
Tax5
63
4.3%
66
3.8%
70
4.1%
331
22.4%
429
24.8%
411
24.3%
61
4.2%
91
5.3%
73
4.3%
269
18.2%
338
19.5%
338
20.0%
Profit after tax
1. Direct costs include material cost, F&B and Clinician's cost, etc.
2. Indirect overheads include personnel cost and other indirect overheads.
3. This is a non-cash item representing change in fair value of contingent consideration payable to Trust/Society over the balance period (~19 to 30 years) under O&M Contracts and
mainly represents impact of changes in the time value of discounted liability
4.
Net of interest income on deposits, capitalisation of projects underway and tax refunds, and includes forex gain/loss, etc.
5. Effective tax rate in Q3 FY24 stood at 17.7% compared to 18.6% in Q3 FY23
25View entire presentation